GSK870086 inhalation / GSK  >>  Phase 2
Welcome,         Profile    Billing    Logout  

8 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK870086 inhalation / GSK
NCT00857857: A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics

Completed
2
24
Europe
GW870086X, FP, Placebo
GlaxoSmithKline
Asthma
11/09
11/09
NCT00945932: A Study to Evaluate the Effect of Repeat Doses of GW870086X in Mild to Moderate Asthmatics

Completed
2
37
Europe
GW870086X, Placebo
GlaxoSmithKline
Asthma
12/09
12/09
NCT01299610: A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo

Completed
2
25
Europe
GW870086 2.0%, GW870086 0.2%, FP 0.05%, Placebo
GlaxoSmithKline
Dermatitis, Atopic
03/11
04/11
2010-022280-35: A randomised, double-blind, placebo-controlled study of topical GW870086X formulation in subjects with moderate or severe atopic dermatitis.

Completed
2
25
Europe
GW870086X, Flutivate® Creme, GW870086X, Flutivate® Creme, Cream, Flutivate Creme
GlaxoSmithKline
subjects with moderate or severe atopic dermatitis.
 
 
NCT01245426: A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)

Completed
2
136
Europe, RoW
GW870086 2mg, GW870086 4mg, GW870086 Placebo, GW870086 1mg, GW870086 3mg
GlaxoSmithKline
Asthma
07/11
08/11
2008-008254-23: A randomised, double-blind, placebo-controlled, 2-way crossover study to determine the efficacy of repeat inhaled doses of GW870086X on FEV1 in mild to moderate asthmatics

Completed
2
36
Europe
GW870086X Rotadisk, GW870086X,
GlaxoSmithKline Research & Development Limited
Asthma
 
12/09
2007-005791-14: A randomised, placebo-controlled, incomplete block, three-way cross-over study to evaluate the effect of treatment with repeat inhaled doses of GW870086X on the allergen-induced early and late asthmatic response in subjects with mild asthma

Completed
2
24
Europe
GW870086X Rotadisk, Fluticasone propionate, 6 Gräsermischung, Methacholine, Birke, Hasel, Katzenhaare, Milbe D.pteronyssinus, Pferdehaare, GW870086X, FP, Flixotide Accuhaler, 6 Gräsermischung, Provocholine, Birke, Hasel, Katzenhaare, Milbe D.pteronyssinus, Pferdehaare, Flixotide Accuhaler, 6 Gräsermischung, Provocholine, Birke, Hasel, Katzenhaare, Milbe D.pteronyssinus, Pferdehaare
GlaxoSmithKline Research & Development Limited
Mild asthma
 
11/09
2010-022279-77: A Phase II Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre Study to determine the efficacy and dose response of repeat inhaled doses of GW870086X on FEV1 in adults with Persistent Asthma

Completed
2
44
Europe
GW870086, GW870086X,
GlaxoSmithKline Research & Development Limited
Asthma
 
07/11

Download Options